Search again:
…are optional). Letter of intent deadline: December 5, 2022, 4:30 p.m. PT Full application deadline (applicant): January 30, 2023, 4:30 p.m. PT Full application deadline (host institution): February 6, 2022,…
…isolated and unable to work. The unit’s secondary focus will be complex disorders affecting memory in old age. Leader: William Honer, MD, LMCC, FRCPC University of British Columbia Members: Alasdair…
In the modern pharmaceutical industrial, a large number of new drug candidates come from molecules isolated from microbes. These “natural products” include some of our most powerful antibiotics, chemotherapeutics, and…
Chronic myelogenous leukemia (CML) is a cancer of the white blood cells. The disease starts when genetic changes in blood stem cells (hematopoietic stem cells, or HSCs) cause them to…
…it occurs early in pregnancy. Dr. Peter von Dadelszen’s program of research covers a broad range of laboratory, clinical and health services research related to pre-eclampsia. He is studying the…
…or contributes to many health problems, including obesity, heart disease, cancer, diabetes, stroke, osteoporosis, birth defects and immune and cognitive impairments. There is a corresponding awareness that specific food components…
…is to understand how defence, repair, and regeneration are regulated and how this knowledge can be exploited to benefit health and offer new treatments for disease. Leader: John Schrader, MBBS,…
…better understanding of Parkinson’s disease, its complications, and related disorders such as depression and addictive behaviours. Leader: A. Jon Stoessl, MD, FRCPC University of British Columbia Members: Michael Adam, PhD…
…including extensive drug resistant strains (XDR-TB). The drug course to clear MDR-TB lasts up to two years, and XDR-TB is virtually untreatable with current therapies. These factors, combined with the…
Immune disorders – such as immunodeficiencies, leukemia and lymphoma, autoimmunity, and allergy – are significant health problems. For example, every year 5,600 Canadians people die of cancers of the immune…